收费全文 | 4961篇 |
免费 | 466篇 |
国内免费 | 674篇 |
2024年 | 19篇 |
2023年 | 94篇 |
2022年 | 160篇 |
2021年 | 337篇 |
2020年 | 263篇 |
2019年 | 333篇 |
2018年 | 238篇 |
2017年 | 203篇 |
2016年 | 225篇 |
2015年 | 328篇 |
2014年 | 377篇 |
2013年 | 374篇 |
2012年 | 487篇 |
2011年 | 419篇 |
2010年 | 250篇 |
2009年 | 235篇 |
2008年 | 239篇 |
2007年 | 205篇 |
2006年 | 165篇 |
2005年 | 159篇 |
2004年 | 136篇 |
2003年 | 132篇 |
2002年 | 118篇 |
2001年 | 94篇 |
2000年 | 74篇 |
1999年 | 55篇 |
1998年 | 36篇 |
1997年 | 36篇 |
1996年 | 32篇 |
1995年 | 33篇 |
1994年 | 27篇 |
1993年 | 22篇 |
1992年 | 25篇 |
1991年 | 17篇 |
1990年 | 19篇 |
1989年 | 14篇 |
1988年 | 11篇 |
1987年 | 7篇 |
1985年 | 5篇 |
1983年 | 12篇 |
1982年 | 5篇 |
1980年 | 4篇 |
1979年 | 4篇 |
1977年 | 4篇 |
1973年 | 6篇 |
1972年 | 11篇 |
1971年 | 7篇 |
1970年 | 7篇 |
1968年 | 7篇 |
1967年 | 4篇 |
Sirtuin 3 (Sirt3) is a member of the Sirtuin family proteins and known to regulate multiple physiological processes such as metabolism and aging. As stroke is an aging-related disease, in this work, we attempt to examine the role and potential mechanism of Sirt3 in regulating ischemic stroke by using a permanent middle cerebral artery occlusion (pMCAO) model in wild type (WT) and Sirt3 knockout (KO) mice, coupled with oxygen glucose deprivation (OGD) experiments in cultured primary astrocytes. Sirt3 deficiency aggravated neuronal cell apoptosis and neurological deficits after brain ischemia. In addition, Sirt3 KO mice showed more severe blood–brain barrier (BBB) disruption and inflammatory responses compared with WT group in the acute phase. Furthermore, specific overexpression of Sirt3 in astrocytes by injecting glial fibrillary acidic protein (GFAP)::Sirt3 virus in ischemic region showed protective effect against stroke-induced damage. Mechanistically, Sirt3 could regulate vascular endothelial growth factor (VEGF) expression by inhibiting hypoxia inducible factor-1α (HIF-1α) signaling after ischemia (OGD). Our results have shown that Sirt3 plays a protective role in ischemic stroke via regulating HIF-1α/VEGF signaling in astrocytes, and reversal of the Sirt3 expression at the acute phase could be a worthy direction for stroke therapy.
相似文献FK1706 is a novel non-immunosuppressive immunophilin ligand with neurotrophic activity and exerts its neurotrophic effect through NGF. The present study aimed to elaborate on the neurotrophic activity and the mechanism of action of FK1706 in end-to-side neurorrhaphy rats and SH-SY5Y cells. In the regenerating nerves of neurorrhaphy rats, FK1706 increased the thickness of myelin sheath and the level of nerve regeneration-related proteins. The mechanism of action of FK1706 on neurite regrowth was elucidated in vitro by incubating SH-SY5Y cells in different conditions (Control, NGF, FK1706, NGF?+?FK1706, NGF?+?FK1706?+?geldanamycin). Under the conditions where NGF was used, the phosphorylation level of major proteins (Raf-1 and ERK) in the Ras/Raf/MAPK/ERK signaling pathway related to SH-SY5Y cell proliferation was significantly enhanced following the application of FK1706. The number of viable cells, cell viability and neurite length of SH-SY5Y cells was maximal when NGF and FK1706 were used simultaneously. The binding level of HSP90 and Raf-1 in FK1706 group was the highest. These results indicated that FK1706 could significantly promote nerve regeneration after neurorrhaphy. The putative mechanism of action stated that FK1706 could promote the binding of HSP90 and Raf-1, make Raf-1 continue to be activated, thereby affecting key proteins in the Ras/Raf/MAPK/ERK signaling pathway related to the neurotrophic effects of NGF to promote the proliferation and neurite regrowth of nerve cells.
相似文献